Literature DB >> 21047302

Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999-2009.

Thomas C Martin1, Michael A Rocque.   

Abstract

OBJECTIVE: To assess the effect of recent availability (due to more home use) of methadone and buprenophine has had on the accidental and non-accidental misuse by children.
METHODS: A retrospective review of all pediatric (< 18 years old) admissions for methadone or buprenorphine ingestion at Eastern Maine Medical Center (EMMC) from September 1, 1999 to August 31, 2009 was performed. Data recorded included age, sex, accidental or non-accidental ingestion, source of drug, ward or pediatric intensive care unit (PICU) admission, treatment given and length of hospital stay. Relation to pediatric emergency department (ED) visits, general pediatric ward admissions and patients on opioid maintenance treatment in the area was also assessed.
RESULTS: There were 22 children (12 female) admitted for methadone (10, 46%) or buprenorphine (12, 54%) ingestion, with ingestions tripling in the later five year period compared with the earlier five years. The trend was statistically significant, unrelated to pediatric ED visits or ward admissions but statistically related to number of patients on opioid maintenance treatment in the region. Of the 22 children with ingestion, six (27%) were adolescents (mean age 15.2 years) and ingestion was intentional (three suicide, three recreational) and 16 were infants or toddlers (mean age 21.6 months) whose ingestions were accidental. The drug source was family and friend (18, 82%) or unknown (four, 18%). There were six patients admitted to the ward and 16 patients (74%) admitted to the PICU. Two patients had observation only, seven had anticipatory intravenous (IV) line placement, nine patients were given IV line and naloxone (bolus + IV infusion), and four patients required endotracheal intubation, IV placement and naloxone. There were no fatalities and mean hospital stay was one to seven days, mean 2.3 days. All families were referred to family services.
CONCLUSIONS: Accidental and non-accidental ingestion of methadone and buprenorphine by children is increasing in proportion to increased clinical use and availability. Health providers should be aware of this increased risk and be able to provide appropriate treatment and family support.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21047302     DOI: 10.2174/157488611794480034

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  13 in total

1.  Analysis of Interventions Required in 12,021 Children With Acute Intoxications Admitted to PICUs.

Authors:  Meral M Patel; Curtis D Travers; Jana A Stockwell; Robert J Geller; Pradip P Kamat; Jocelyn R Grunwell
Journal:  Pediatr Crit Care Med       Date:  2017-07       Impact factor: 3.624

2.  Reducing Childhood Admissions to the PICU for Poisoning (ReCAP2) by Predicting Unnecessary PICU Admissions After Acute Intoxication.

Authors:  Meral M Patel; Curtis D Travers; Jana A Stockwell; Ezaldeen A Numur; Robert J Geller; Pradip P Kamat; Jocelyn R Grunwell
Journal:  Pediatr Crit Care Med       Date:  2018-02       Impact factor: 3.624

3.  Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.

Authors:  Bradley D Stein; Rosalie Liccardo Pacula; Adam J Gordon; Rachel M Burns; Douglas L Leslie; Mark J Sorbero; Sebastian Bauhoff; Todd W Mandell; Andrew W Dick
Journal:  Milbank Q       Date:  2015-09       Impact factor: 4.911

4.  Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.

Authors:  Laura B Monico; Shannon Gwin Mitchell; Jan Gryczynski; Robert P Schwartz; Kevin E O'Grady; Yngvild K Olsen; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2015-05-07

5.  Buprenorphine and its formulations: a comprehensive review.

Authors:  Salomon Poliwoda; Nazir Noor; Jack S Jenkins; Cain W Stark; Mattie Steib; Jamal Hasoon; Giustino Varrassi; Ivan Urits; Omar Viswanath; Adam M Kaye; Alan D Kaye
Journal:  Health Psychol Res       Date:  2022-08-20

6.  Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.

Authors:  Brian J Piper; Clare E Desrosiers; John W Lipovsky; Matthew A Rodney; Robert P Baker; Kenneth L McCall; Stephanie D Nichols; Sarah L Martin
Journal:  J Stud Alcohol Drugs       Date:  2016-07       Impact factor: 2.582

7.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

8.  Outpatient Opioid Prescriptions for Children and Opioid-Related Adverse Events.

Authors:  Cecilia P Chung; S Todd Callahan; William O Cooper; William D Dupont; Katherine T Murray; Andrew D Franklin; Kathi Hall; Judith A Dudley; C Michael Stein; Wayne A Ray
Journal:  Pediatrics       Date:  2018-07-16       Impact factor: 7.124

Review 9.  A review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.

Authors:  Michelle R Lofwall; Sharon L Walsh
Journal:  J Addict Med       Date:  2014 Sep-Oct       Impact factor: 3.702

10.  Clinical Signs and Symptoms and Laboratory Findings of Methadone Poisoning in Children.

Authors:  Mohammad Reza Sharif; Saeed Nouri
Journal:  Iran J Pediatr       Date:  2015-01-17       Impact factor: 0.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.